Kevin P. Cunningham

Système et méthode pour le control en temps réel de multimédia à protocolles multiples

Kevin P. Cunningham, Eric L. Singer, 2001 .

The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels

Kevin P. Cunningham, A. Mathie, E. Veale, 2021, Frontiers in Pharmacology.

Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension

Kevin P. Cunningham, A. Mathie, P. Escribano-Subías, 2018, The Journal of physiology.

Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release

Kevin P. Cunningham, M. Shankar-Hari, S. Luqman, 2022, Scientific Reports.

Similar voltage-sensor movement in spHCN channels can cause closing, opening, or inactivation

Kevin P. Cunningham, H. Larsson, Xiaoan Wu, 2023, The Journal of general physiology.

Functional properties and pharmacological regulation of two-pore domain potassium channels associated with pulmonary disorders

Kevin P. Cunningham, 2018 .

Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels

Kevin P. Cunningham, A. Mathie, D. Macintyre, 2019, Acta physiologica.

The Role of the K2P Channels TASK‐1, TREK‐1 and TREK‐2 in the Use of Treprostinil Therapy in Pulmonary Arterial Hypertension

Kevin P. Cunningham, A. Mathie, E. Veale, 2018 .